Enfusion EBIT

Enfusion (ENFN) currently reports a EBIT of $3.2M as of December 2024. That compares with $12M in the prior-year period — down 73.4% year over year. That is below the Technology sector average of $14T. Use the charts on this page to explore Enfusion's EBIT history and peer comparisons.

Enfusion's EBIT decreased from $12M to $3.2M — a 73.4% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enfusion's EBIT of $3.2M is lower than the Technology sector average of $14T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Enfusion reported $3.2M in EBIT as of December 2024. That compares with $12M in the prior-year period — down 73.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $3.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $14T. From there, open related valuation or income-statement pages for Enfusion, and consider following ENFN for alerts when major investors trade the stock.